Cite
HARVARD Citation
Olivotto, I. et al. (2020). Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 396 (10253), pp. 759-769. [Online].